AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28341261 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlusive drainage system
Number of subjects: 28
Study 28341261 — intervention group
Group type: COMPARATOR
Intervention: Conventional indirect wet dressing method
Number of subjects: 28
Study 25453872 — intervention group
Group type: COMPARATOR
Intervention: Conventional antimicrobial susceptibility testing
Number of subjects: 39
Study 25453872 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofilm antimicrobial susceptibility testing
Number of subjects: 39
Study 23870605 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation: Amlodipine orotate 10 mg and valsartan 160 mg
Number of subjects: 50
Study 23870605 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation: Amlodipine besylate 10 mg and valsartan 160 mg
Number of subjects: 50
Study 20980201 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril (ACE inhibitor)
Number of subjects: 31546
Study 20980201 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan (Angiotensin-receptor blocker)
Number of subjects: 31546
Study 20980201 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment (ramipril + telmisartan)
Number of subjects: 31546
Study 20980201 — intervention group
Group type: COMPARATOR
Intervention: Telmisartan
Number of subjects: 31546
Study 20980201 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31546
Study 19165682 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 90
Study 19165682 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 17464690 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol or risperidone for 8 weeks (exact dosage not specified)
Number of subjects: 16
Study 17464690 — intervention group
Group type: COMPARATOR
Intervention: N/A (Control group)
Number of subjects: 16
Study 17464690 — intervention group
Group type: EXPERIMENTAL
Intervention: N/A (FEP group)
Number of subjects: 16
Study 15099798 — intervention group
Group type: EXPERIMENTAL
Intervention: FUSS model
Number of subjects: 0
Study 15099798 — intervention group
Group type: COMPARATOR
Intervention: Latent Semantic Analysis
Number of subjects: 0
Study 15099798 — intervention group
Group type: COMPARATOR
Intervention: Similarity metrics derived from Wordnet
Number of subjects: 0
Study 11299422 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG without cardiopulmonary bypass (CPB)
Number of subjects: 20
Study 11299422 — intervention group
Group type: COMPARATOR
Intervention: CABG with cardiopulmonary bypass (CPB)
Number of subjects: 20
Study 11299422 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG without CPB
Number of subjects: 20
Study 11299422 — intervention group
Group type: COMPARATOR
Intervention: CABG with CPB
Number of subjects: 20
Study 10211026 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopental 5 mg kg‐1 (group TH)
Number of subjects: 93
Study 10211026 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil 10 micrograms kg‐1 and propofol 3 mg kg‐1 (group PAH)
Number of subjects: 93
Study 10211026 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% Halothane (group HH)
Number of subjects: 93
Study 10211026 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 93
Study 8740606 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 10
Study 8740606 — intervention group
Group type: COMPARATOR
Intervention: Magnesium chloride
Number of subjects: 10
Study 2180661 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy aimed at near normalization of blood glucose levels
Number of subjects: 1441
Study 2180661 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 1441
Study 6102878 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlormethiazole (384 mg)
Number of subjects: 40
Study 6102878 — intervention group
Group type: EXPERIMENTAL
Intervention: Temazepam (20 mg)
Number of subjects: 40
Study 6102878 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 30677465 — intervention group
Group type: EXPERIMENTAL
Intervention: Treat-and-extend (T&E) regimen with intravitreal ranibizumab at a dose of 0.5 mg
Number of subjects: 526
Study 30677465 — intervention group
Group type: COMPARATOR
Intervention: Monthly dosing regimen with intravitreal ranibizumab at a dose of 0.5 mg
Number of subjects: 526
Study 30677465 — intervention group
Group type: EXPERIMENTAL
Intervention: Treat-and-extend (T&E) regimen
Number of subjects: 526
Study 30677465 — intervention group
Group type: COMPARATOR
Intervention: Monthly dosing regimen
Number of subjects: 526
Study 28605779 — intervention group
Group type: EXPERIMENTAL
Intervention: DAPT (aspirin and clopidogrel) for 24 months
Number of subjects: 1970
Study 28605779 — intervention group
Group type: COMPARATOR
Intervention: DAPT (aspirin and clopidogrel) for 6 months
Number of subjects: 1970
Study 25811946 — intervention group
Group type: EXPERIMENTAL
Intervention: Isomaltulose (ISO)
Number of subjects: 9
Study 25811946 — intervention group
Group type: COMPARATOR
Intervention: Fructose-Maltodextrin (F:M)
Number of subjects: 9
Study 25811946 — intervention group
Group type: COMPARATOR
Intervention: Placebo-flavored water (PL)
Number of subjects: 9
Study 23400994 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuff inflation technique with silicone-tipped wire reinforced (SWR) ET tube
Number of subjects: 162
Study 23400994 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuff inflation technique with polyvinyl chloride (PVC) ET tube
Number of subjects: 162
Study 23400994 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuff inflation technique with wire reinforced (WR) ET tube
Number of subjects: 162
Study 23400994 — intervention group
Group type: COMPARATOR
Intervention: Silicone-tipped wire reinforced (SWR) ET tube
Number of subjects: 162
Study 21334592 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term culture (Optisol-GS; Bausch & Lomb) at 4 C (group A; n = 37)
Number of subjects: 82
Study 21334592 — intervention group
Group type: EXPERIMENTAL
Intervention: Organ culture (Dulbecco Modified Eagle Medium [Biochrom]; CorneaMax Medium [Eurobio]) at 34 C (group B; n = 45)
Number of subjects: 82
Study 19723755 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine-131 treatment
Number of subjects: 313
Study 19723755 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment (antithyroid drugs)
Number of subjects: 313
Study 18001249 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 4%
Number of subjects: 26
Study 18001249 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracaine 1%
Number of subjects: 26
Study 18001249 — intervention group
Group type: EXPERIMENTAL
Intervention: Both substances
Number of subjects: 26
Study 15103949 — intervention group
Group type: EXPERIMENTAL
Intervention: Flex Plug (FP)
Number of subjects: 37
Study 15103949 — intervention group
Group type: COMPARATOR
Intervention: Eagle Plug (EP)
Number of subjects: 37
Study 11561769 — intervention group
Group type: EXPERIMENTAL
Intervention: FEC (5-fluorouracil, epirubicin, and cyclophosphamide) - 9 cycles with dose escalation
Number of subjects: 105
Study 11561769 — intervention group
Group type: COMPARATOR
Intervention: CTCb (3 cycles of FEC followed by high-dose chemotherapy with alkylating agents)
Number of subjects: 105
Study 11561769 — intervention group
Group type: EXPERIMENTAL
Intervention: FEC (5-fluorouracil, epirubicin, and cyclophosphamide)
Number of subjects: 105
Study 11561769 — intervention group
Group type: EXPERIMENTAL
Intervention: Left-sided chest irradiation
Number of subjects: 105
Study 8612853 — intervention group
Group type: EXPERIMENTAL
Intervention: Crossover trials
Number of subjects: 5291
Study 8612853 — intervention group
Group type: COMPARATOR
Intervention: Parallel group trials
Number of subjects: 5291
Study 1593071 — intervention group
Group type: EXPERIMENTAL
Intervention: CooperVision Permaflex Mystique opaque tinted lens
Number of subjects: 22
Study 1593071 — intervention group
Group type: EXPERIMENTAL
Intervention: Wesley-Jessen Durasoft 3 Colors opaque tinted lens
Number of subjects: 22
Study 1593071 — intervention group
Group type: COMPARATOR
Intervention: CooperVision CV Classic non-opaque control lens
Number of subjects: 22
Study 1593071 — intervention group
Group type: COMPARATOR
Intervention: Wesley-Jessen Durasoft 3 clear lens
Number of subjects: 22
Study 1593071 — intervention group
Group type: EXPERIMENTAL
Intervention: Wesley-Jessen Durasoft 3 opaque lens
Number of subjects: 22
Study 6689799 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline delivered via extension tube (250 micrograms)
Number of subjects: 11
Study 6689799 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline delivered via extension tube (250, 500, and 750 micrograms)
Number of subjects: 11
Study 6689799 — intervention group
Group type: COMPARATOR
Intervention: Terbutaline delivered by regular pressurized aerosol device (250, 500, and 750 micrograms)
Number of subjects: 11
Study 30285589 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal statement evaluation by six experienced internship candidate evaluators
Number of subjects: 100
Study 30285589 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative analysis of personal statements
Number of subjects: 100
Study 30630803 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 126
Study 30630803 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive ventilation
Number of subjects: 126
Study 30630803 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination group (Dexmedetomidine + Continuous Positive Airway Pressure)
Number of subjects: 126
Study 26614548 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy only
Number of subjects: 169
Study 26614548 — intervention group
Group type: EXPERIMENTAL
Intervention: Total population
Number of subjects: 169
Study 25348723 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard 30:2 CPR (ST‐CPR)
Number of subjects: 36
Study 25348723 — intervention group
Group type: COMPARATOR
Intervention: Chest compression-only CPR (CO‐CPR)
Number of subjects: 36
Study 25885506 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous 1 g tranexamic acid 20 min before skin incision
Number of subjects: 60
Study 25885506 — intervention group
Group type: COMPARATOR
Intervention: Normal saline as placebo (Control)
Number of subjects: 60
Study 20218943 — intervention group
Group type: EXPERIMENTAL
Intervention: Polytetrafluoroethylene (PTFE) grafts
Number of subjects: 0
Study 20218943 — intervention group
Group type: COMPARATOR
Intervention: Polyurethane (PVAG) grafts
Number of subjects: 0
Study 17326028 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-propanol 60% vol/vol (A)
Number of subjects: 24
Study 17326028 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-propanol 70% m/m plus chlorhexidine gluconate 0.5% wt/wt (B)
Number of subjects: 24
Study 17326028 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-propanol 45% wt/wt plus 1-propanol 30% wt/wt plus mecetronium etilsulfate 0.2% wt/wt (C)
Number of subjects: 24
Study 17326028 — intervention group
Group type: COMPARATOR
Intervention: 1-propanol 60% vol/vol, unstained (R)
Number of subjects: 24
Study 16248471 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation (20g/day for 7 days followed by 10g/day for 21 days)
Number of subjects: 18
Study 16248471 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation
Number of subjects: 18
Study 16248471 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 18
Study 11896865 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural surfactant (Alveofact)
Number of subjects: 92
Study 11896865 — intervention group
Group type: COMPARATOR
Intervention: Synthetic surfactant (Exosurf)
Number of subjects: 92
Study 10097253 — intervention group
Group type: EXPERIMENTAL
Intervention: 33h of fasting
Number of subjects: 11
Study 10097253 — intervention group
Group type: COMPARATOR
Intervention: Regular meals (control)
Number of subjects: 11
Study 7749764 — intervention group
Group type: EXPERIMENTAL
Intervention: OND + DEX
Number of subjects: 33
Study 7749764 — intervention group
Group type: COMPARATOR
Intervention: OND
Number of subjects: 33
Study 7749764 — intervention group
Group type: COMPARATOR
Intervention: Both arms
Number of subjects: 33
Study 2032107 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative oral lactulose (n = 35)
Number of subjects: 102
Study 2032107 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sodium deoxycholate (n = 32)
Number of subjects: 102
Study 2032107 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific treatment, n = 35)
Number of subjects: 102
Study 6754509 — intervention group
Group type: EXPERIMENTAL
Intervention: verapamil 120 mg t.d.s.
Number of subjects: 19
Study 6754509 — intervention group
Group type: COMPARATOR
Intervention: propranolol 160 mg b.d.
Number of subjects: 19
Study 30885120 — intervention group
Group type: EXPERIMENTAL
Intervention: Education and self-management intervention for chronic headache, delivered over two days.
Number of subjects: 18
Study 30885120 — intervention group
Group type: EXPERIMENTAL
Intervention: Education and self-management intervention for chronic headache, refined based on pilot feedback.
Number of subjects: 18
Study 27838190 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormonal therapy with vigabatrin
Number of subjects: 377
Study 27838190 — intervention group
Group type: COMPARATOR
Intervention: Hormonal therapy alone
Number of subjects: 377
Study 26885881 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg DHEA (women)
Number of subjects: 152
Study 26885881 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg DHEA (men)
Number of subjects: 152
Study 26885881 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg T (men)
Number of subjects: 152
Study 26885881 — intervention group
Group type: COMPARATOR
Intervention: Placebo (women)
Number of subjects: 152
Study 26885881 — intervention group
Group type: COMPARATOR
Intervention: Placebo (men)
Number of subjects: 152
Study 24439640 — intervention group
Group type: EXPERIMENTAL
Intervention: Reiki therapy
Number of subjects: 38
Study 24439640 — intervention group
Group type: COMPARATOR
Intervention: Sham Reiki (control)
Number of subjects: 38
Study 22157811 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor control training program (15-week intervention)
Number of subjects: 0
Study 22157811 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor control training program (8-week intervention)
Number of subjects: 0
Study 22157811 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (7-week intervention)
Number of subjects: 0
Study 19649513 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest physician support
Number of subjects: 868
Study 19649513 — intervention group
Group type: EXPERIMENTAL
Intervention: Software support
Number of subjects: 868
Study 19649513 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 868
Study 17457187 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjunctival limbal autograft (group 1)
Number of subjects: 78
Study 17457187 — intervention group
Group type: COMPARATOR
Intervention: Amniotic membrane transplantation (AMT) (group 2)
Number of subjects: 78
Study 15180336 — intervention group
Group type: EXPERIMENTAL
Intervention: HPMC capsules
Number of subjects: 11
Study 15180336 — intervention group
Group type: COMPARATOR
Intervention: Gelatin capsules
Number of subjects: 11
Study 11361053 — intervention group
Group type: EXPERIMENTAL
Intervention: Linezolid with pseudoephedrine
Number of subjects: 0
Study 11361053 — intervention group
Group type: EXPERIMENTAL
Intervention: Linezolid with phenylpropanolamine
Number of subjects: 0
Study 11361053 — intervention group
Group type: EXPERIMENTAL
Intervention: Linezolid with dextromethorphan
Number of subjects: 0
Study 11361053 — intervention group
Group type: COMPARATOR
Intervention: Linezolid alone
Number of subjects: 0
Study 9620567 — intervention group
Group type: EXPERIMENTAL
Intervention: ORS + CBJ
Number of subjects: 80
Study 9620567 — intervention group
Group type: COMPARATOR
Intervention: ORS
Number of subjects: 80
Study 8057000 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (50 or 100 mg/day)
Number of subjects: 269
Study 8057000 — intervention group
Group type: EXPERIMENTAL
Intervention: Dothiepin (75 or 150 mg/day)
Number of subjects: 269
Study 8057000 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 269
Study 3127265 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine (H2 blocker)
Number of subjects: 12
Study 3127265 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous enteral nutrition
Number of subjects: 12
Study 3127265 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31051499 — intervention group
Group type: EXPERIMENTAL
Intervention: Pistachio-supplemented diet (PD, 50 E% carbohydrates and 33 E% fat, including 57 g pistachios/d)
Number of subjects: 49
Study 31051499 — intervention group
Group type: EXPERIMENTAL
Intervention: Pistachio-supplemented diet (PD)
Number of subjects: 49
Study 31051499 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric control diet (CD, 55 E% carbohydrates and 30 E% fat)
Number of subjects: 49
Study 27488933 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramosetron 0.3 mg
Number of subjects: 3
Study 27488933 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramosetron 0.45 mg
Number of subjects: 3
Study 27488933 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramosetron 0.6 mg
Number of subjects: 3
Study 27488933 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramosetron (all doses)
Number of subjects: 3
Study 25556682 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 0
Study 25556682 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS
Number of subjects: 0
Study 25556682 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 0
Study 22496083 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stents (PES)
Number of subjects: 103
Study 22496083 — intervention group
Group type: COMPARATOR
Intervention: Bare metal stents (BMS)
Number of subjects: 103
Study 19808911 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone
Number of subjects: 904
Study 19808911 — intervention group
Group type: COMPARATOR
Intervention: Glyburide
Number of subjects: 904
Study 19808911 — intervention group
Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 904
Study 17903391 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG)
Number of subjects: 2437
Study 17903391 — intervention group
Group type: COMPARATOR
Intervention: Valproate (VPS)
Number of subjects: 2437
Study 17903391 — intervention group
Group type: COMPARATOR
Intervention: Carbamazepine (CBZ)
Number of subjects: 2437
Study 17903391 — intervention group
Group type: COMPARATOR
Intervention: Topiramate (TPM)
Number of subjects: 2437
Study 17903391 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of Life (QoL) assessments
Number of subjects: 2437
Study 17903391 — intervention group
Group type: EXPERIMENTAL
Intervention: Health economic analysis
Number of subjects: 2437
Study 17903391 — intervention group
Group type: COMPARATOR
Intervention: Health economic assessment for VPS
Number of subjects: 2437
Study 15652310 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain activity measured during emotional facial expression stimuli
Number of subjects: 0
Study 15652310 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional face stimuli
Number of subjects: 0
Study 14562597 — intervention group
Group type: COMPARATOR
Intervention: Prostaglandin E2 pessary
Number of subjects: 406
Study 14562597 — intervention group
Group type: COMPARATOR
Intervention: Vaginal misoprostol
Number of subjects: 406
Study 14562597 — intervention group
Group type: COMPARATOR
Intervention: Oral misoprostol
Number of subjects: 406
Study 14562597 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin F2 alpha gel
Number of subjects: 406
Study 10544953 — intervention group
Group type: EXPERIMENTAL
Intervention: VLDL from NIDDM patients
Number of subjects: 43
Study 10544953 — intervention group
Group type: EXPERIMENTAL
Intervention: VLDL from IDDM patients
Number of subjects: 43
Study 10544953 — intervention group
Group type: COMPARATOR
Intervention: VLDL and HDL from healthy subjects
Number of subjects: 43
Study 10544953 — intervention group
Group type: EXPERIMENTAL
Intervention: HDL from NIDDM patients
Number of subjects: 43
Study 10544953 — intervention group
Group type: COMPARATOR
Intervention: HDL from healthy subjects
Number of subjects: 43
Study 7599911 — intervention group
Group type: EXPERIMENTAL
Intervention: Metosil (10 mg)
Number of subjects: 18
Study 7599911 — intervention group
Group type: COMPARATOR
Intervention: Plasil BP (10 mg)
Number of subjects: 18
Study 2221413 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g carnitine intravenously before cardiopulmonary bypass (CPB)
Number of subjects: 0
Study 2221413 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 g carnitine intravenously before cardiopulmonary bypass (CPB)
Number of subjects: 0
Study 2221413 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study 304478 — intervention group
Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMZ)
Number of subjects: 50
Study 304478 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentamidine isethionate
Number of subjects: 50
Study 30798143 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent administered resilience component in conjunction with stuttering therapy
Number of subjects: 28
Study 30798143 — intervention group
Group type: COMPARATOR
Intervention: Fluency therapy only
Number of subjects: 28
Study 30392386 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative structure‐property relationship models using various 2D molecular descriptors derived from single repeating units of polymers.
Number of subjects: 206
Study 30392386 — intervention group
Group type: EXPERIMENTAL
Intervention: Models validated through cross-validation, external validation, Y-randomization test, and applicability domain study.
Number of subjects: 206
Study 30392386 — intervention group
Group type: COMPARATOR
Intervention: Comparison with previously published models based on smaller datasets.
Number of subjects: 206
Study 27176449 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Exercise (PE) group (n = 80)
Number of subjects: 117
Study 27176449 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 37)
Number of subjects: 117
Study 25358227 — intervention group
Group type: EXPERIMENTAL
Intervention: Volar subcutaneous digital block
Number of subjects: 126
Study 25358227 — intervention group
Group type: COMPARATOR
Intervention: Dorsal two injections block
Number of subjects: 126